News Story: Full Text
Sponsored By
AbbVie
Please Click On The Above Banner For More Details
Braintumor Website

 

FDA Approves NextSource`s Brain Tumor Treatment

Al's Comment:

 This is an old drug - CCNU - but a new capsule size was just approved by the FDA.  It is commonly used in combination with Avastin.  The standard dose is 130mg/m2 which for a 200 pound 6' tall person works out to about 275 mg... They already had capsules of 100mg, 40 mg and 10mg.  SO I guess this allows for finer control of the dose - however, some insurance companies charge a copay on each capsule size.


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.pharmpro.com/news/2016/01/fda-approves-nextsources-brain-tumor-treatment


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740